Nabriva Therapeutics plc Temporary Equity, Accretion to Redemption Value
Nabriva Therapeutics plc reported Temporary Equity, Accretion to Redemption Value of $3.88 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-16.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityAccretionToRedemptionValue · last filed 2018-03-16
- Nabriva Therapeutics plc temporary equity, accretion to redemption value for fiscal 2015 was $3.88M, a 1918.23% increase from fiscal 2014.
- Nabriva Therapeutics plc temporary equity, accretion to redemption value for fiscal 2014 was $192.00K.
| Period end | Temporary Equity, Accretion to Redemption Value 12 month |
|---|---|
| 2015-12-31 | $3.88M 10-K · filed 2018-03-16 |
| 2014-12-31 | $192.00K 10-K · filed 2017-03-24 |